BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramachandran A, Snehalatha C, Mary S, Selvam S, Kumar CK, Seeli AC, Shetty AS. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia. 2009;52:1019-1026. [PMID: 19277602 DOI: 10.1007/s00125-009-1315-x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Fisher M. Glitazones and Glitazars. Diabetes Drug Notes 2022. [DOI: 10.1002/9781119785033.ch12] [Reference Citation Analysis]
2 Nanditha A, Susairaj P, Raghavan A, Vinitha R, Satheesh K, Nair DR, Jeyaraj S, Snehalatha C, Ramachandran A. Concordance in incidence of diabetes among persons with prediabetes detected using either oral glucose tolerance test or glycated haemoglobin. Prim Care Diabetes 2022:S1751-9918(22)00033-X. [PMID: 35337771 DOI: 10.1016/j.pcd.2022.02.004] [Reference Citation Analysis]
3 Dagogo-Jack S, Umekwe N, Brewer AA, Owei I, Mupparaju V, Rosenthal R, Wan J. Outcome of lifestyle intervention in relation to duration of pre-diabetes: the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study. BMJ Open Diabetes Res Care 2022;10:e002748. [PMID: 35273012 DOI: 10.1136/bmjdrc-2021-002748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021;42:59-77. [PMID: 33355476 DOI: 10.1146/annurev-publhealth-090419-102644] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
5 Muilwijk M, Loh M, Siddiqui S, Mahmood S, Palaniswamy S, Shahzad K, Athauda LK, Jayawardena R, Batool T, Burney S, Glover M, Bamunuarachchi V, Panda M, Madawanarachchi M, Rai B, Sattar I, Silva W, Waghdhare S, Jarvelin MR, Rannan-Eliya RP, Wijemunige N, Gage HM, Valabhji J, Frost GS, Wickremasinghe R, Kasturiratne A, Khawaja KI, Ahmad S, van Valkengoed IG, Katulanda P, Jha S, Kooner JS, Chambers JC. Effects of a lifestyle intervention programme after 1 year of follow-up among South Asians at high risk of type 2 diabetes: a cluster randomised controlled trial. BMJ Glob Health 2021;6:e006479. [PMID: 34725039 DOI: 10.1136/bmjgh-2021-006479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jonas DE, Crotty K, Yun JDY, Middleton JC, Feltner C, Taylor-Phillips S, Barclay C, Dotson A, Baker C, Balio CP, Voisin CE, Harris RP. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;326:744-60. [PMID: 34427595 DOI: 10.1001/jama.2021.10403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
7 Smokovski I. Diabetes Drivers. Managing Diabetes in Low Income Countries 2021. [DOI: 10.1007/978-3-030-51469-3_2] [Reference Citation Analysis]
8 Ipsen EØ, Madsen KS, Chi Y, Pedersen-Bjergaard U, Richter B, Metzendorf MI, Hemmingsen B. Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus. Cochrane Database Syst Rev 2020;11:CD013516. [PMID: 33210751 DOI: 10.1002/14651858.CD013516.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, Lau ESH, Eliasson B, Kong APS, Ezzati M, Aguilar-Salinas CA, McGill M, Levitt NS, Ning G, So WY, Adams J, Bracco P, Forouhi NG, Gregory GA, Guo J, Hua X, Klatman EL, Magliano DJ, Ng BP, Ogilvie D, Panter J, Pavkov M, Shao H, Unwin N, White M, Wou C, Ma RCW, Schmidt MI, Ramachandran A, Seino Y, Bennett PH, Oldenburg B, Gagliardino JJ, Luk AOY, Clarke PM, Ogle GD, Davies MJ, Holman RR, Gregg EW. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet 2021;396:2019-82. [PMID: 33189186 DOI: 10.1016/S0140-6736(20)32374-6] [Cited by in Crossref: 132] [Cited by in F6Publishing: 146] [Article Influence: 66.0] [Reference Citation Analysis]
10 Yeu RQ, Brandon R, Jiang Y, Griffiths D, Smallman K, Moffitt A, Doherty G, Paul R, Harré Hindmarsh J, Merriman TR, Macaskill-Smith K, Orr-Walker B, Murphy R. Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol. BMJ Open 2020;10:e036518. [PMID: 32873667 DOI: 10.1136/bmjopen-2019-036518] [Reference Citation Analysis]
11 Akinnuga AM, Siboto A, Khumalo B, Sibiya NH, Ngubane P, Khathi A. Ameliorative Effects of Bredemolic Acid on Markers Associated with Renal Dysfunction in a Diet-Induced Prediabetic Rat Model. Oxid Med Cell Longev 2020;2020:2978340. [PMID: 32655765 DOI: 10.1155/2020/2978340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Sallar A, Dagogo-Jack S. Regression from prediabetes to normal glucose regulation: State of the science. Exp Biol Med (Maywood) 2020;245:889-96. [PMID: 32212859 DOI: 10.1177/1535370220915644] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
13 Akinnuga AM, Siboto A, Khumalo B, Sibiya NH, Ngubane P, Khathi A. Bredemolic Acid Improves Cardiovascular Function and Attenuates Endothelial Dysfunction in Diet-Induced Prediabetes: Effects on Selected Markers. Cardiovasc Ther 2020;2020:1936406. [PMID: 32117470 DOI: 10.1155/2020/1936406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Yamaoka K, Nemoto A, Tango T. Comparison of the Effectiveness of Lifestyle Modification with Other Treatments on the Incidence of Type 2 Diabetes in People at High Risk: A Network Meta-Analysis. Nutrients 2019;11:E1373. [PMID: 31248094 DOI: 10.3390/nu11061373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
15 Al-dajah K, Al-kassar A, Al-shdaifat A. Predictors of conversion from prediabetic state to type 2 diabetes mellitus in Jordan. Alexandria Journal of Medicine 2018;54:451-3. [DOI: 10.1016/j.ajme.2018.10.003] [Reference Citation Analysis]
16 Brannick B, Dagogo-Jack S. Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction. Endocrinol Metab Clin North Am 2018;47:33-50. [PMID: 29407055 DOI: 10.1016/j.ecl.2017.10.001] [Cited by in Crossref: 91] [Cited by in F6Publishing: 105] [Article Influence: 30.3] [Reference Citation Analysis]
17 Fagg J, Valabhji J. How do we identify people at high risk of Type 2 diabetes and help prevent the condition from developing? Diabet Med 2019;36:316-25. [PMID: 30466172 DOI: 10.1111/dme.13867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Mechanick JI, Garber AJ, Grunberger G, Handelsman Y, Garvey WT. Dysglycemia-Based Chronic Disease: An American Association of Clinical Endocrinologists Position Statement. Endocrine Practice 2018;24:995-1011. [DOI: 10.4158/ps-2018-0139] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]
19 Braga T, Kraemer-Aguiar LG, Docherty NG, Le Roux CW. Treating prediabetes: why and how should we do it? Minerva Med 2019;110:52-61. [PMID: 30371047 DOI: 10.23736/S0026-4806.18.05897-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
20 Ramachandran A, Kumar R, Nanditha A, Raghavan A, Snehalatha C, Krishnamoorthy S, Joshi P, Tesfaye F. mDiabetes initiative using text messages to improve lifestyle and health-seeking behaviour in India. BMJ Innov 2018;4:155-62. [DOI: 10.1136/bmjinnov-2017-000265] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
21 Aziz Z, Mathews E, Absetz P, Sathish T, Oldroyd J, Balachandran S, Shetty SS, Thankappan KR, Oldenburg B. A group-based lifestyle intervention for diabetes prevention in low- and middle-income country: implementation evaluation of the Kerala Diabetes Prevention Program. Implement Sci 2018;13:97. [PMID: 30021592 DOI: 10.1186/s13012-018-0791-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
22 Muilwijk M, Nicolaou M, Qureshi SA, Celis-Morales C, Gill JMR, Sheikh A, Sattar N, Beune E, Jenum AK, Stronks K, van Valkengoed IGM. Dietary and physical activity recommendations to prevent type 2 diabetes in South Asian adults: A systematic review. PLoS One 2018;13:e0200681. [PMID: 30011314 DOI: 10.1371/journal.pone.0200681] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
23 Thankappan KR, Sathish T, Tapp RJ, Shaw JE, Lotfaliany M, Wolfe R, Absetz P, Mathews E, Aziz Z, Williams ED, Fisher EB, Zimmet PZ, Mahal A, Balachandran S, D'Esposito F, Sajeev P, Thomas E, Oldenburg B. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program. PLoS Med 2018;15:e1002575. [PMID: 29874236 DOI: 10.1371/journal.pmed.1002575] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 19.3] [Reference Citation Analysis]
24 Sangle GV, Patil M, Deshmukh NJ, Shengule SA, Kamble S, Vuppalavanchu KK, Kale S, Baig MLA, Singh G, Shaikh J, Tripathi J, Aravindababu P. Evaluation of pharmacokinetic and pharmacodynamic parameters following single dose of sitagliptin in healthy Indian males. Eur J Clin Pharmacol 2018;74:561-9. [PMID: 29511780 DOI: 10.1007/s00228-018-2433-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Montgomery B. The Pillars of Prevention: Discover, Advocate, and Educate. Diabetes Spectr 2018;31:99-104. [PMID: 29456433 DOI: 10.2337/ds17-0078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Khetan AK, Rajagopalan S. Prediabetes. Can J Cardiol 2018;34:615-23. [PMID: 29731022 DOI: 10.1016/j.cjca.2017.12.030] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
27 Mathews E, Thomas E, Absetz P, D'Esposito F, Aziz Z, Balachandran S, Daivadanam M, Thankappan KR, Oldenburg B. Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala diabetes prevention program (K-DPP). BMC Public Health 2018;17:974. [PMID: 29298703 DOI: 10.1186/s12889-017-4986-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
28 Pai SA, Kshirsagar NA. Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report. Indian J Med Res 2016;144:672-81. [PMID: 28361819 DOI: 10.4103/ijmr.IJMR_650_15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Brannick B, Wynn A, Dagogo-Jack S. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Exp Biol Med (Maywood) 2016;241:1323-31. [PMID: 27302176 DOI: 10.1177/1535370216654227] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 15.2] [Reference Citation Analysis]
30 Kabadi UM. Major Pathophysiology in Prediabetes and Type 2 Diabetes: Decreased Insulin in Lean and Insulin Resistance in Obese. J Endocr Soc 2017;1:742-50. [PMID: 29264527 DOI: 10.1210/js.2016-1116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
31 Abate N, Chandalia M. Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians. Gastroenterology 2017;152:1647-55. [PMID: 28192110 DOI: 10.1053/j.gastro.2017.01.046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
32 Dagogo-jack S. Primary Prevention of Type 2 Diabetes: An Imperative for Developing Countries. Diabetes Mellitus in Developing Countries and Underserved Communities 2017. [DOI: 10.1007/978-3-319-41559-8_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Sathish T, Oldenburg B, Tapp RJ, Shaw JE, Wolfe R, Sajitha B, D'Esposito F, Absetz P, Mathews E, Zimmet PZ, Thankappan KR. Baseline characteristics of participants in the Kerala Diabetes Prevention Program: a cluster randomized controlled trial of lifestyle intervention in Asian Indians. Diabet Med 2017;34:647-53. [PMID: 27279083 DOI: 10.1111/dme.13165] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
34 Hostalek U, Gwilt M, Hildemann S. Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs 2015;75:1071-94. [PMID: 26059289 DOI: 10.1007/s40265-015-0416-8] [Cited by in Crossref: 143] [Cited by in F6Publishing: 109] [Article Influence: 23.8] [Reference Citation Analysis]
35 Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163:437-451. [PMID: 26167912 DOI: 10.7326/m15-0452] [Cited by in Crossref: 187] [Cited by in F6Publishing: 206] [Article Influence: 26.7] [Reference Citation Analysis]
36 Checkley W, Ghannem H, Irazola V, Kimaiyo S, Levitt NS, Miranda JJ, Niessen L, Prabhakaran D, Rabadán-Diehl C, Ramirez-Zea M, Rubinstein A, Sigamani A, Smith R, Tandon N, Wu Y, Xavier D, Yan LL; GRAND South Network, UnitedHealth Group/National Heart, Lung, and Blood Institute Centers of Excellence. Management of NCD in low- and middle-income countries. Glob Heart 2014;9:431-43. [PMID: 25592798 DOI: 10.1016/j.gheart.2014.11.003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 10.1] [Reference Citation Analysis]
37 Priscilla S, Nanditha A, Simon M, Satheesh K, Kumar S, Shetty AS, Snehalatha C, Johnston DG, Godsland IF, Wareham NJ, Ramachandran A. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India-Outcome of screening. Diabetes Res Clin Pract 2015;110:335-40. [PMID: 26547503 DOI: 10.1016/j.diabres.2015.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
38 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 258] [Article Influence: 34.7] [Reference Citation Analysis]
39 Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, Davies M, Goyder E. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract 2015;107:320-31. [PMID: 25638454 DOI: 10.1016/j.diabres.2015.01.027] [Cited by in Crossref: 86] [Cited by in F6Publishing: 98] [Article Influence: 12.3] [Reference Citation Analysis]
40 Shah A, Kanaya AM. Diabetes and associated complications in the South Asian population. Curr Cardiol Rep. 2014;16:476. [PMID: 24643902 DOI: 10.1007/s11886-014-0476-5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
41 Misra A, Ramchandran A, Jayawardena R, Shrivastava U, Snehalatha C. Diabetes in South Asians. Diabet Med 2014;31:1153-62. [DOI: 10.1111/dme.12540] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 8.1] [Reference Citation Analysis]
42 Dyson PA. Addressing noncommunicable disease at the population level: a focus on diabetes. Diabetes Management 2014;4:153-163. [DOI: 10.2217/dmt.13.75] [Reference Citation Analysis]
43 Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab. 2014;16:719-727. [PMID: 24476122 DOI: 10.1111/dom.12270] [Cited by in Crossref: 99] [Cited by in F6Publishing: 108] [Article Influence: 12.4] [Reference Citation Analysis]
44 RISE Consortium. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span. Diabetes Care. 2014;37:780-788. [PMID: 24194506 DOI: 10.2337/dc13-1879] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
45 Journal of Diabetes NEWS. Journal of Diabetes 2013;5:97-101. [DOI: 10.1111/1753-0407.12036] [Reference Citation Analysis]
46 Wang Z, Wang J, Chan P. Treating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbs. Evid Based Complement Alternat Med 2013;2013:343594. [PMID: 23737828 DOI: 10.1155/2013/343594] [Cited by in Crossref: 31] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
47 Ambady R, Snehalatha C, Samith Shetty A, Nanditha A. Primary prevention of Type 2 diabetes in South Asians - challenges and the way forward: Primary prevention of Type 2 diabetes in South Asians. Diabetic Medicine 2013;30:26-34. [DOI: 10.1111/j.1464-5491.2012.03753.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
48 Soriguer F, Rubio-martín E, Rojo-martínez G. Prevención de la diabetes mellitus tipo 2. Medicina Clínica 2012;139:640-6. [DOI: 10.1016/j.medcli.2012.03.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Hsu WC, Boyko EJ, Fujimoto WY, Kanaya A, Karmally W, Karter A, King GL, Look M, Maskarinec G, Misra R. Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications. Diabetes Care. 2012;35:1189-1198. [PMID: 22517940 DOI: 10.2337/dc12-0212] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
50 Yakubovich N, Gerstein HC. Is regression to normoglycaemia clinically important? Lancet. 2012;379:2216-2218. [PMID: 22683127 DOI: 10.1016/s0140-6736(12)60828-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
51 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
52 Palitzsch K, Bührlen M. So kann die Diabetesflut eingedämmt werden: Screening und frühzeitige Präventionsmaßnahmen. MMW - Fortschritte der Medizin 2012;154:45-9. [DOI: 10.1007/s15006-012-0586-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
53 Garduño-Diaz SD, Khokhar S. Prevalence, risk factors and complications associated with type 2 diabetes in migrant South Asians. Diabetes Metab Res Rev 2012;28:6-24. [PMID: 21591242 DOI: 10.1002/dmrr.1219] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
54 Ramachandran A, Snehalatha C, Samith Shetty A, Nanditha A. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance-analysis of the Indian Diabetes Prevention Programmes: HbA1c and incident diabetes. Diabetic Medicine 2012;29:94-8. [DOI: 10.1111/j.1464-5491.2011.03392.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
55 Moutzouri E, Tsimihodimos V, Rizos E, Elisaf M. Prediabetes: to treat or not to treat? Eur J Pharmacol. 2011;672:9-19. [PMID: 22020287 DOI: 10.1016/j.ejphar.2011.10.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
56 Hopper I, Billah B, Skiba M, Krum H. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur J Cardiovasc Prev Rehabil 2011;18:813-23. [PMID: 21878448 DOI: 10.1177/1741826711421687] [Cited by in Crossref: 97] [Cited by in F6Publishing: 112] [Article Influence: 8.8] [Reference Citation Analysis]
57 Sudhakaran C, Kishore U, Anjana RM, Unnikrishnan R, Mohan V. Effectiveness of sitagliptin in asian Indian patients with type 2 diabetes-an Indian tertiary diabetes care center experience. Diabetes Technol Ther 2011;13:27-32. [PMID: 21175268 DOI: 10.1089/dia.2010.0120] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
58 Ramachandran A, Snehalatha C. Diabetes prevention programs. Med Clin North Am 2011;95:353-72, viii. [PMID: 21281838 DOI: 10.1016/j.mcna.2010.11.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
59 Boyko EJ, Gerstein HC, Mohan V, Yusuf S, Sheridan P, Anand S, Shaw JE; DREAM trial investigators. Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabet Med 2010;27:1226-32. [PMID: 20950379 DOI: 10.1111/j.1464-5491.2010.03064.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
60 Ramachandran A, Arun N, Shetty AS, Snehalatha C. Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2). Diabetes Care 2010;33:2164-8. [PMID: 20519663 DOI: 10.2337/dc09-1150] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
61 . Current literature in diabetes. Diabetes Metab Res Rev 2009;25:i-x. [PMID: 19790194 DOI: 10.1002/dmrr.1037] [Reference Citation Analysis]
62 Vig J. Ethnicity-associated variance in efficacy of pioglitazone as a preventive tool. Nat Rev Endocrinol 2009;5:355-355. [DOI: 10.1038/nrendo.2009.85] [Reference Citation Analysis]